Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Science › EchoStar’s stock has fallen alongside SpaceX’s — but it...
Science

EchoStar’s stock has fallen alongside SpaceX’s — but it may now be worth another look

EchoStar’s stock has fallen alongside SpaceX’s — but it may now be worth another look
MarketWatch Friday 17 July 2026, 16:18 UTC By William Gavin 1 min read
Key Points

EchoStar’s stock has for months been seen as a way to more cheaply get exposure to SpaceX.

EchoStar’s stock has for months been seen as a way to more cheaply get exposure to SpaceX.
SpaceX (ORG)
Originally published by MarketWatch Read original →

Related Stories

EU proposes slowing down cuts to carbon emissions for businesses

Under the proposals, the EU plans to relax its emissions trading system to give companies more time to reduce their carbon output.

BBC Science 13m ago

EU proposes slowing down cuts to carbon emissions for businesses

Under the proposals, the EU plans to relax its emissions trading system to give companies more time to reduce their carbon output.

BBC Science 13m ago

'RNA can do things which we have never seen before': New study challenges assumptions about what RNA was up to at the dawn of life

'RNA can do things which we have never seen before': New study challenges assumptions about what RNA was up to at the dawn of life RNA can fold into more complex configurations than scientists thought, raising questions about how important these 3D structures were when life on Earth began. Scientists long thought that when RNA kick-started life on Earth 4 billion years ago, it could form only small, simple structures.

Live Science 45m ago

Troubling new details emerge on diabetes ouster controversy

Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New Orleans. On June 5, five leading scientists were ousted for handing out copies of an editorial, published in the journal Diabetes Care (an ADA journal) in April, sharply criticizing the Trump administration’s ongoing attacks on scientific research. There was a public outcry and (eventually) a personal apology from the ADA's CEO for the heavy-handed response, but it seems...

Ars Technica Science 57m ago